Toorop AA, Noteboom S, Steenwijk MD, Gravendeel JW, et al. Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Mult Scler 2024 Jan 18:13524585231225855. doi: 10.1177/13524585231225855.
PMID: 38235514